The present invention includes pourable, non-toxic lubricating compositions containing carrageenan and more precisely carrageenan as an anti-viral agent, for protection from Human Papillomavirus (HPV), and methods of using the lubricating compositions as a non-oily, psuedoplastic lubrication product and administering the carrageenan for reducing the propagation of HPV during sexual activity.

The present invention provides crude extracts from the red seaweeds: Polysiphonia lanosa (PL), Polysiphonia urceloata (PU), Cystoclonium purpureum (CP) and Devaleraea ramentacia (DR), method of preparation and their use for inhibiting the growth of microbial cells, particularly bacteria causing acne, such as Propionibacterium acnes, or causing nosocomial infections such as MRSA in humans or MRSP in dogs.

The present invention provides crude extracts from the red seaweeds: Polysiphonia lanosa (PL), Polysiphonia urceloata (PU), Cystoclonium purpureum (CP) and Devaleraea ramentacia (DR), method of preparation and their use for inhibiting the growth of microbial cells, particularly bacteria causing acne, such as Propionibacterium acnes, or causing nosocomial infections such as MRSA in humans or MRSP in dogs.

Antimicrobial, antiviral and antifungal composition and methods of use thereof are provided.

Antimicrobial, antiviral and antifungal composition and methods of use thereof are provided.

A method of preparing an antiviral Grateloupia chiangii-derived lectin, includes preparing a crude extract of Grateloupia chiangii that is a red alga; and purifying a Grateloupia chiangii-derived lectin (GLC) from the crude extract by means of electrophoresis using D-mannose affinity chromatography. The present invention is expected to be useful in the field of medicine and pharmaceuticals in the future by identifying an amino acid sequence of the purified lectin and a complementary base sequence coding for the purified lectin.

Disclosed herein are ionic aqueous compositions useful as nasal passage washes to aid in the resorption of edema of the respiratory mucosa, e.g., the nasal mucosa, for the treatment of respiratory tract and/or respiratory mucosal-related conditions, including, e.g., chronic rhinosinusitis, sinusitis, allergic rhinitis and nasal polyps. The composition includes an ionic aqueous solution and algae-derived constituents, such as branched, sulfated polysaccharides having an average molecular weight greater than 4 kDa and comprising L-fucose and sulfate ester groups or extracts from brown algae. Also disclosed are methods and pharmaceutical compositions for treating respiratory tract and/or respiratory mucosal-related conditions, including, e.g., chronic rhinosinusitis.

Disclosed herein are ionic aqueous compositions useful as nasal passage washes to aid in the resorption of edema of the respiratory mucosa, e.g., the nasal mucosa, for the treatment of respiratory tract and/or respiratory mucosal-related conditions, including, e.g., chronic rhinosinusitis, sinusitis, allergic rhinitis and nasal polyps. The composition includes an ionic aqueous solution and algae-derived constituents, such as branched, sulfated polysaccharides having an average molecular weight greater than 4 kDa and comprising L-fucose and sulfate ester groups or extracts from brown algae. Also disclosed are methods and pharmaceutical compositions for treating respiratory tract and/or respiratory mucosal-related conditions, including, e.g., chronic rhinosinusitis.

Process with the aim of preventing or slowing the appearance of unattractive signs, generated by the pollutants present in the atmosphere, on the skin, the scalp, the hair or the mucous membranes, or indeed of eliminating them, including a step of application of a cosmetic formulation for topical use, including at least one cosmetically acceptable excipient and an effective amount of at least one glycolic extract (GE) of a unialgal biomass of small multicellular macroalgae originating from the Florideophyceae class. The extract, for the use thereof in a therapeutic method for treating signs of irritation of the skin, the scalp or the mucous membranes, manifesting as redness, sensations of stinging and/or itching, signs of deterioration of the hair, manifesting as an increase in the porosity thereof, the dulling thereof, and/or the weakening thereof with regard to mechanical stresses.

The present invention relates to a pad for treating skin diseases, comprising agar gel and a fiber layer fixed to the inside of the gel, and a manufacturing method therefor. The pad of the present invention inhibits blood vessel exudation symptoms according to vasodilation by maintaining a low temperature of the affected area, reduces an itchy sensation and, at the same time, removes, from the skin, plasma proteins and various plasma-derived substances accumulated in skin tissue, thereby having an effect of alleviating the symptoms of the affected area.